Core Viewpoint - The Tianjin Free Trade Zone concept has shown a significant increase of 1.90%, leading the concept sector in terms of growth, with several stocks reaching their daily limit up [1][2]. Group 1: Stock Performance - Within the Tianjin Free Trade Zone concept, six stocks experienced gains, with Tianbao Construction, Guifaxiang, and Bohai Chemical hitting the daily limit up [1]. - Notable performers included Tianjin Port, HNA Technology, and Ji'an Medical, which rose by 1.80%, 0.68%, and 0.51% respectively [1]. - Conversely, Hengyin Technology, Tianjin Pulin, and Jinkai New Energy faced declines of 2.05%, 1.72%, and 1.41% respectively [1]. Group 2: Capital Inflow - The Tianjin Free Trade Zone concept saw a net inflow of 248 million yuan from major funds, with nine stocks receiving net inflows [2]. - Guifaxiang led the net inflow with 115 million yuan, followed by Tianbao Construction, Bohai Chemical, and HNA Technology with net inflows of 79.36 million yuan, 49.21 million yuan, and 19.02 million yuan respectively [2][3]. - The net inflow ratios for Guifaxiang, Tianbao Construction, and Bohai Chemical were 35.49%, 30.77%, and 23.17% respectively, indicating strong investor interest [3].

证券代码：002432 证券简称：九安医疗 公告编号：2025-020 天津九安医疗电子股份有限公司 关于与专业投资机构共同投资的进展公告 二、投资的进展情况 公司于近日收到基金管理人深圳市汇芯股权投资管理有限公司的通知， 苏州清智创业投资合伙企业（有限合伙）已募集完成，截至目前已收到全体 合伙人实缴资本金，募集资金总额为 19,600.10 万元，合伙人及其出资情况 如下： | 序号 | 合伙人名称 | 合伙人 | 出资 | 出资额 | 出资比例 | | --- | --- | --- | --- | --- | --- | | | | 类型 | 方式 | （万元） | | | 1 | 安吉清智企业管理合伙企业（有限合伙） | GP | 现金出资 | 100 | 0.51% | | 2 | 深圳市汇芯股权投资管理有限公司 | GP | 现金出资 | 0.1 | 0.00% | | 3 | 天津九安医疗电子股份有限公司 | LP | 现金出资 | 2,000.00 | 10.20% | | 4 | 其他合伙人 | LP | 现金出资 | 17,500.00 | 89.29% | | | 合计 | - | - ...

数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构 成投资建议。 证券之星消息，根据天眼查APP数据整理，近日，德州九致电子科技有限公司成立，法定代表人为李 康，注册资本50万元，经营范围包含：一般项目：技术服务、技术开发、技术咨询、技术交流、技术转 让、技术推广；电子元器件与机电组件设备销售；通讯设备销售；广播电视传输设备销售；计算机软硬 件及辅助设备零售；计算机软硬件及辅助设备批发；机械设备销售；电子产品销售；照相机及器材销 售；体育用品及器材零售；日用百货销售；家用电器销售；家用电器零配件销售；气体、液体分离及纯 净设备销售；环境监测专用仪器仪表销售；办公用品销售；服装服饰零售；鞋帽零售；眼镜销售（不含 隐形眼镜）；箱包销售；家具销售；厨具卫具及日用杂品批发；厨具卫具及日用杂品零售；日用品销 售；日用玻璃制品销售；食品用洗涤剂销售；汽车零配件批发；汽车零配件零售；电池零配件销售；塑 料制品销售；玻璃纤维增强塑料制品销售；风动和电动工具销售；卫生洁具销售；玩具、动漫及游艺用 品销售；体育用品及器材批发；摩托车及零配件批发； ...

Core Viewpoint - The China Securities Index for Healthcare Equipment and Services has shown a mixed performance, with a recent increase but a decline over the past month and year-to-date [1] Group 1: Index Performance - The CSI Healthcare Equipment and Services Index rose by 0.32% to 13,285.51 points, with a trading volume of 13.924 billion yuan [1] - Over the past month, the index has decreased by 8.06%, while it has increased by 4.05% over the last three months and has declined by 3.25% year-to-date [1] Group 2: Index Composition - The index is composed of listed companies in the healthcare sector, reflecting the overall performance of these securities [1] - The top ten weighted companies in the index include Mindray Medical (9.16%), Aier Eye Hospital (8.31%), and United Imaging Healthcare (7.43%) [1] - The index is primarily composed of companies listed on the Shenzhen Stock Exchange (60.27%) and the Shanghai Stock Exchange (39.73%) [1] Group 3: Sample Adjustment and Fund Tracking - The index samples are adjusted biannually, with adjustments occurring on the second Friday of June and December [2] - Public funds tracking the healthcare index include several funds from Southern Asset Management and Tianhong Asset Management [2]

天眼查工商信息显示，近日，天津九安医疗（002432）电子股份有限公司出资50万元成立聊城九凰电子 科技有限公司，持股100%，所属行业为计算机、通信和其他电子设备制造业。 资料显示，聊城九凰电子科技有限公司成立于2025年4月10日，法定代表人为李康，注册资本50万人民 币，公司位于聊城市，技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广、电子专用设 备销售、五金产品批发、计算机系统服务、电子元器件零售、信息技术咨询服务、通讯设备销售、电子 元器件与机电组件设备销售、科技中介服务、家用电器销售、电子元器件与机电组件设备制造、工程和 技术研究和试验发展、信息系统集成服务、数字视频监控系统销售、软件开发、企业管理、网络与信息 安全软件开发、物联网技术服务、电子产品销售、计算机软硬件及辅助设备批发、计算机软硬件及辅助 设备零售、计算机及办公设备维修、电子元器件批发、计算机软硬件及外围设备制造、电子专用材料研 发、安全系统监控服务、电子专用设备制造、电子元器件制造、网络技术服务、物联网技术研发、电 子、机械设备维护(不含特种设备)、通信设备销售、服装服饰零售、鞋帽零售、服装服饰批发、鞋帽批 发、服装辅料销 ...

从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均46.15倍，行业中值29.13倍，九安医疗排 名第28位。 4月10日，九安医疗今日收盘36.61元，上涨1.84%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到10.05倍，总市值173.20亿元。 最新一期业绩显示，2024年三季报，公司实现营业收入20.92亿元，同比-23.79%；净利润13.69亿元，同 比52.63%，销售毛利率71.68%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)28九安医疗10.0513.840.90173.20亿行业平均 46.1548.384.77102.50亿行业中值29.1329.012.3143.45亿1硕世生物-1773.70-1773.701.1136.64亿2诺唯 赞-508.88-508.882.3392.08亿3博晖创新-340.62-209.723.7552.28亿4康泰医学-270.0231.682.7652.52亿5华 大基因-198.46217.092.05201.67亿6奥精医疗-108.48-108.481.3819.65亿7睿昂基因-79.90-79.901 ...

Company Overview - Jiuan Medical, established in 1995, focuses on the development and production of health-related electronic products and smart hardware [1] - The company aims to build a personal health management cloud platform integrating smart hardware, mobile applications, and cloud services [1] Recent Performance - Jiuan Medical has experienced a decline in stock price, with a cumulative drop of -15.75% over the last five trading days [1] - The company is among the top ten shareholders of Guangfa Fund, which increased its holdings in the last quarter of the previous year [1] Fund Management - The fund manager of Guangfa Medical Healthcare Stock A is Wu Xingwu, who has a background in science and holds a certificate in securities investment [4][5] - Wu Xingwu has managed various funds since 2015, including Guangfa Core Selected Mixed Fund and Guangfa Medical Healthcare Stock Fund [4][5] Fund Performance - Guangfa Medical Healthcare Stock A has achieved a year-to-date return of 4.73%, ranking 73rd out of 1001 in its category [1]

Company Overview - Jiuan Medical closed at 37.36 yuan on April 7, down 10.00%, with a rolling PE ratio of 10.26 times and a total market value of 17.675 billion yuan [1] - The company specializes in the research, production, and sales of home medical devices, as well as cloud platform systems and services, gradually transforming into an Internet + medical solution provider [1] Financial Performance - For the latest financial report, Jiuan Medical achieved an operating income of 2.092 billion yuan for the third quarter of 2024, a year-on-year decrease of 23.79% [1] - The net profit for the same period was 1.369 billion yuan, reflecting a year-on-year increase of 52.63%, with a sales gross margin of 71.68% [1] Industry Comparison - The average PE ratio for the medical device industry is 43.33 times, with a median of 27.80 times, placing Jiuan Medical at the 28th position in the industry ranking [2] - The company’s PE ratio is significantly lower than the industry average, indicating potential undervaluation compared to peers [2]

资料显示，德州九专电子科技有限公司成立于2025年4月3日，法定代表人为李康，注册资本50万人民 币，公司位于德州市，技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广、电子元器件 与机电组件设备销售、通讯设备销售、广播电视传输设备销售、计算机软硬件及辅助设备零售、计算机 软硬件及辅助设备批发、机械设备销售、电子产品销售、照相机及器材销售、体育用品及器材零售、日 用百货销售、家用电器销售、家用电器零配件销售、气体、液体分离及纯净设备销售、环境监测专用仪 器仪表销售、办公用品销售、服装服饰零售、鞋帽零售、眼镜销售（不含隐形眼镜）、箱包销售、家具 销售、厨具卫具及日用杂品批发、厨具卫具及日用杂品零售、日用品销售、日用玻璃制品销售、食品用 洗涤剂销售、汽车零配件批发、汽车零配件零售、电池零配件销售、塑料制品销售、玻璃纤维增强塑料 制品销售、风动和电动工具销售、卫生洁具销售、玩具、动漫及游艺用品销售、体育用品及器材批发、 摩托车及零配件批发、摩托车及零配件零售、文具用品批发、文具用品零售、电工仪器仪表销售、智能 仪器仪表销售、针纺织品销售、钟表销售、钟表与计时仪器销售、珠宝首饰批发、珠宝首饰零售、工艺 美术品 ...

证券代码：002432 证券简称：九安医疗 公告编号：2025-018 天津九安医疗电子股份有限公司 关于部分募集资金投资项目延期、结项及 节余募集资金使用的公告 本公司及董事会全体成员保证公告内容真实、准确和完整， 并对公告中的虚假记载、误导性陈述或者重大遗漏承担连带责任。 天津九安医疗电子股份有限公司（以下简称："公司"、"九安公司"）于 2025 年 4 月 3 日召开了第六届董事会第二十次会议、第六届监事会第十五次会议，审 议通过了《关于部分募集资金投资项目延期、结项及节余募集资金使用的议案》。 鉴于公司募集资金项目"糖尿病照护服务及相关产品研发项目"之子项目"共同照 护中心扩展及系统研发升级项目"已经完成结项，为提高募集资金使用效率，进 一步满足新增人才的扩容及办公需要和智能家用医疗器械的研发需求，以及推动 持续血糖监测系统（CGMS）研发项目的加速实施，公司拟将剩余募集资金用于 "研发办公总部大楼建设及原厂区升级改造项目"和"糖尿病照护服务及相关产 品研发项目"之子项目"持续血糖监测系统（CGMS）研发项目"。 根据《上市公司监管指引第 2 号—上市公司募集资金管理和使用的监管要 求》和《深圳证券 ...